EUVIMEDEUVIMED entdecken
Crossref

The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients

Yutaka Shimazu, Junya Kanda, Teruhito Takakuwa, Yoshiyuki Onda, Kentaro Fukushima, Masaaki Hotta, Shin-Ichi Fuchida, Nobuhiko Uoshima, Yuji Shimura, Hirokazu Tanaka, Kensuke Ohta, Hirohiko Shibayama und 10 weitere

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05934-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Yutaka Shimazu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Graduate School of Medicine, Kyoto University, 54, Kawaramachi, Shogoin, Sakyoku, Kyoto, 606-8507, Japan. yshimazu@kuhp.kyo…. Hauptthemen laut MEDLINE: Multiple Myeloma, Glomerular Filtration Rate, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaGlomerular Filtration RateAntineoplastic Combined Chemotherapy ProtocolsHumansAgedMaleFemaleAged, 80 and overDexamethasoneBortezomibMelphalanLenalidomideRenal InsufficiencyAntibodies, MonoclonalPrednisoloneRetrospective StudiesPrognosis

Stichwörter der Autor:innen

Multiple myelomaOverall survivalPrognosisRenal dysfunctionTransplant-ineligible

Substanzen

DexamethasoneBortezomibMelphalanLenalidomidedaratumumabAntibodies, MonoclonalPrednisolone

Autor:innen und Institutionen

  • Department of Hematology, Graduate School of Medicine, Kyoto University, 54, Kawaramachi, Shogoin, Sakyoku, Kyoto, 606-8507, Japan. yshimazu@kuhp.kyoto-u.ac.jp.
  • Department of Early Clinical Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan. yshimazu@kuhp.kyoto-u.ac.jp.
  • Department of Hematology, Graduate School of Medicine, Kyoto University, 54, Kawaramachi, Shogoin, Sakyoku, Kyoto, 606-8507, Japan.
  • Department of Hematology, Wakakusa Daiichi Hospital, Nara, Japan.
  • Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan.
  • Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Shimazu, Y., Kanda, J., Takakuwa, T., Onda, Y., Fukushima, K., Hotta, M., Fuchida, S. I., Uoshima, N., Shimura, Y., Tanaka, H., Ohta, K., Shibayama, H., Kosugi, S., Yagi, H., Yoshihara, S., Hosen, N., Ito, T., Shimazaki, C., Matsumura, I., …, & Hino, M. (2024). The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients. Annals of Hematology. https://doi.org/10.1007/s00277-024-05934-2

Vancouver

Shimazu Y, Kanda J, Takakuwa T, Onda Y, Fukushima K, Hotta M, et al. The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients. Annals of Hematology. 2024. doi:10.1007/s00277-024-05934-2

BibTeX
@article{Shimazu2024,
  author = {Shimazu, Yutaka and Kanda, Junya and Takakuwa, Teruhito and Onda, Yoshiyuki and Fukushima, Kentaro and Hotta, Masaaki and Fuchida, Shin-Ichi and Uoshima, Nobuhiko and Shimura, Yuji and Tanaka, Hirokazu and Ohta, Kensuke and Shibayama, Hirohiko and Kosugi, Satoru and Yagi, Hideo and Yoshihara, Satoshi and Hosen, Naoki and Ito, Tomoki and Shimazaki, Chihiro and Matsumura, Itaru and Kuroda, Junya and Takaori-Kondo, Akifumi and Hino, Masayuki},
  title = {The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05934-2}
}
Kostenlos starten →